NASDAQ: CRDL
Cardiol Therapeutics Inc Stock Ownership - Who owns Cardiol Therapeutics?

Insider buying vs selling

Have Cardiol Therapeutics Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when CRDL insiders and whales buy or sell their stock.

CRDL Shareholders

What type of owners hold Cardiol Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Tejara Capital Ltd3.95%3,265,819$3.49MInstitution
Advisorshares Investments LLC1.04%857,388$917.41kInstitution
Lion Street Advisors LLC0.41%340,025$363.83kInstitution
Mmcap International Inc Spc0.35%293,056$313.57kInstitution
Pvg Asset Management Corp0.34%283,472$303.32kInstitution
Cambridge Investment Research Advisors Inc0.25%206,265$220.70kInstitution
Envestnet Asset Management Inc0.22%181,682$194.40kInstitution
Ubs Group Ag0.17%139,244$148.99kInstitution
Knoll Capital Management LLC0.12%100,000$107.00kInstitution
Mgo One Seven LLC0.12%100,000$107.00kInstitution

1 of 3

CRDL vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CRDL7.82%0.00%
ASRT26.03%21.24%Net Selling
INCR5.29%0.00%
QNTM3.36%0.00%
KALA6.74%93.26%Net BuyingNet Selling

Cardiol Therapeutics Stock Ownership FAQ

Who owns Cardiol Therapeutics?

Cardiol Therapeutics (NASDAQ: CRDL) is owned by 7.82% institutional shareholders, 0.00% Cardiol Therapeutics insiders, and 92.18% retail investors. Tejara Capital Ltd is the largest individual Cardiol Therapeutics shareholder, owning 3.27M shares representing 3.95% of the company. Tejara Capital Ltd's Cardiol Therapeutics shares are currently valued at $3.49M.

If you're new to stock investing, here's how to buy Cardiol Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.